Substituted isoquinoline1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3ones and 1,4-dihydro-3(2H)-isoquinolones and use thereof as kinase inhibitor

Details for Australian Patent Application No. 2006331765 (hide)

Owner Wyeth

Inventors Nilakantan, Ramaswamy; Tran, Tritan; Liu, Xiaoxiang; Kutterer, Kristina M.K.; Reich, Marvin; Kaplan, Joshua; Zask, Arie; Birnberg, Gary Harold; Floyd, Middleton Brawner; Tang, Zhilian; Otteng, Mercy Adufa; Tsou, Hwei-Ru; Ayral-Kaloustian, Semiramis

Agent Davies Collison Cave

Pub. Number AU-A-2006331765

PCT Pub. Number WO2007/075783

Priority 60/753,701 22.12.05 US

Filing date 20 December 2006

Wipo publication date 5 July 2007

International Classifications

C07D 217/24 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 237/28 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/075783 Priority application(s): WO2007/075783

28 August 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Nilakantan, Ramaswamy; Tran, Tritin; Liu, Xiaoxiang; Kutterer, Kristina M.K.; Reich, Marvin; Kaplan, Joshua; Zask, Arie; Birnberg, Gary Harold; Floyd, Middleton Brawner; Tang, Zhilian; Otteng, Mercy Adufa; Tsou, Hwei-Ru and Ayral-Kaloustian, Semiramis 2007

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331770-Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and H3 receptor antagonist/inverse agonist

2006331759-Powder coating composition providing low gloss